Equally, extracellular HE4 has been shown to enhance proliferation in endometrial cancer cell lines in vitro ([28,29], so HE4 could be a driver of increased tumour aggressiveness, proliferation and resistance to progestogens rather than simply a product of it. Here, WFDC2 is linked to endometrial cancer.